Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Galarce GD, Foncea RE, Edwards AM, Pessoa-Mahana H, Pessoa-Mahana CD, Ebensperger RA (2008) Biological evaluation of novel 6-arylbenzimidazo [1,2-c]quinazoline derivatives as inhibitors of LPS-induced TNF-alpha secretion. Biol Res 41:1–7
2. Bahekar RH, Rao ARR (2000) Bronchodilation and structure-activity relationship studies on new 6-substituted benzimidazo [1,2-c] quinazolines. Arzneim Forsch Drug Res. 50(8):712–716
3. Kuarm BS, Reddy YT, Madhav JV, Crooks PA, Rajitha B (2011) 3-[Benzimidazoand 3-[benzothiadiazoleimidazo-(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones as potent antimicrobial agents. Bioorg Med Chem Lett 21:524–527
4. Rohini R, Shanker K, Reddy PM, Ravinder V (2010) Synthesis and antimicrobial activities of a new class of 6-arylbenzimidazo [1, 2-c] quinazolines. J Braz Chem Soc 21(1):49–57
5. Joshi PP, Shirodkar SG (2014) A new approach for the synthesis of 6-aryl-5,6-dihydrobenzimidazo[1,2-c]quinazoline derivatives and its biological study. World J Pharm Pharm Sci. 3(9):950–958
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Imidazo[1,2-c]quinazolines as a novel and potent scaffold of α-glucosidase inhibitors: design, synthesis, biological evaluations, and in silico studies;Scientific Reports;2023-09-21
2. Study the pharmacological potential of 1,2,4-thiadiazine 1,1-dioxides: A minireview;Al Mustansiriyah Journal of Pharmaceutical Sciences;2023-01-15
3. Anticancer Activity and High Content Screening of New 6-Substituted-5,6-dihydrobenzo[4,5]imidazo[1,2-c]quinazoline Derivatives;Research Journal of Pharmacy and Technology;2021-05-26